Skip to main content
. 2004 Jan;1(1):139–154. doi: 10.1602/neurorx.1.1.139

TABLE 2.

Average Annual Rate of Decline in UPDRS Scores in the DATATOP Study.

Treatment Total UPDRS
Placebo 14.02 ± 12.32
Tocopherol 15.16 ± 16.12
Selegiline 7.00 ± 10.76
Tocopherol and selegiline 7.28 ± 11.11
p Value between the selegiline groups and the placebo/tocopherol groups <0.001

Results are expressed as mean ± SD. From Parkinson Study Group, 1993.119